For: | Meng QQ, Gao Y, Lin H, Wang TJ, Zhang YR, Feng J, Li ZS, Xin L, Wang LW. Application of an artificial intelligence system for endoscopic diagnosis of superficial esophageal squamous cell carcinoma. World J Gastroenterol 2022; 28(37): 5483-5493 [PMID: 36312830 DOI: 10.3748/wjg.v28.i37.5483] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i37/5483.htm |
Number | Citing Articles |
1 |
Lihui Zhang, Liwen Yao, Zihua Lu, Honggang Yu. Current status of quality control in screening esophagogastroduodenoscopy and the emerging role of artificial intelligence. Digestive Endoscopy 2024; 36(1): 5 doi: 10.1111/den.14649
|
2 |
Ji-Han Qi, Shi-Ling Huang, Shi-Zhu Jin. Novel milestones for early esophageal carcinoma: From bench to bed. World Journal of Gastrointestinal Oncology 2024; 16(4): 1104-1118 doi: 10.4251/wjgo.v16.i4.1104
Abstract(41) |
Core Tip(41) |
Full Article(HTML)(239)
|
Full Article with Cover (PDF)-4949K(9)
|
Audio-95K(0)
|
Peer-Review Report-310K(5)
|
Answering Reviewers-1577K(6)
|
Supplementary Material-993K(10)
|
Full Article (PDF)-4723K(17)
|
Full Article (XML)-268K(4)
|
Times Cited (0)
|
Total Visits (521)
|
Open
|
3 |
Farhang Hosseini, Farkhondeh Asadi, Hassan Emami, Mahdi Ebnali. Machine learning applications for early detection of esophageal cancer: a systematic review. BMC Medical Informatics and Decision Making 2023; 23(1) doi: 10.1186/s12911-023-02235-y
|
4 |
Xiang-Lei Yuan, Bing Hu. Comprehensive screening for superficial oesophageal squamous cell carcinoma and precancerous lesions – Authors' reply. The Lancet Gastroenterology & Hepatology 2024; 9(4): 292 doi: 10.1016/S2468-1253(24)00003-7
|
5 |
Xiang-Lei Yuan, Wei Liu, Yi-Xiu Lin, Qian-Yi Deng, Yuan-Ping Gao, Ling Wan, Bin Zhang, Tao Zhang, Wan-Hong Zhang, Xiao-Gang Bi, Guo-Dong Yang, Bi-Hui Zhu, Fan Zhang, Xiao-Bo Qin, Feng Pan, Xian-Hui Zeng, Hunza Chaudhry, Mao-Yin Pang, Juliana Yang, Jing-Yu Zhang, Bing Hu. Effect of an artificial intelligence-assisted system on endoscopic diagnosis of superficial oesophageal squamous cell carcinoma and precancerous lesions: a multicentre, tandem, double-blind, randomised controlled trial. The Lancet Gastroenterology & Hepatology 2024; 9(1): 34 doi: 10.1016/S2468-1253(23)00276-5
|